Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest Rodenticides Stories

c52b8e5c055a1c350dae877a069c58ef
2011-07-22 06:15:00

A new study shows how house mice found unexpected ways to evolve resistance to a common poison and thrive, despite humanity's best efforts to keep them at bay. Rice University researchers analyzed a genetic mutation that has given ordinary European house mice this extraordinary ability. The gene in question, known as vkorc1, is present in all mammals and manages vitamin K.  They found that a mutation to vkorc1 makes mice resistant to warfarin, an anticoagulant used as a blood thinner...

2011-03-01 06:00:00

BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated at Overlake Hospital Medical Center in Bellevue and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events....

2011-03-01 06:00:00

BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated at WellStar Health System in Marietta and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Warfarin, the...

2011-03-01 06:00:00

BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Warfarin, the most commonly prescribed blood thinner...

2011-01-20 07:46:44

(Ivanhoe Newswire) -- More than 31 million prescriptions were written for warfarin in 2004. Now, researchers have reason to believe that the anticoagulant drug may be linked to post-injury death. The drug, which is used to prevent various types of blood clot formations and for abnormal heart rhythm, mechanical heart valves and, in certain cases, heart attack, was scrutinized by Vanderbilt University Medical Center researchers in a recent study set for publication in the Archives of Surgery's...

2011-01-03 15:08:54

Researchers from Boston University School of Medicine (BUSM) and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range (TTR) should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes. These findings appear in this month's issue of Circulation: Cardiovascular Quality and Outcomes. Oral anticoagulation with warfarin is received by millions of Americans each year to treat blood clots and to prevent strokes. While...

2010-11-16 00:00:49

Wool.labs, a business intelligence company driven by social cognition technology, has published a revealing study through SmartBrief, showing confusion among patients and disagreement among physician specialties about the appropriate use of anticoagulants such as Coumadin. The study found that patients steadily increased their self-education efforts from 1999 through 2010 due to differing physician attitudes towards treatment and inconsistent information. Wayne, Pa. (PRWEB) November 15, 2010...

2010-11-15 19:44:30

Increased communication between doctors and patients is key, say researchers at Intermountain Medical Center Heart Institute in Salt Lake City Herbal and dietary supplements are popular. People claim they make their joints feel better, their bones stronger, and their hearts healthier. But a recent study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City shows that many of these people may not realize their favorite supplement, mixed with prescription...

2010-04-07 14:02:00

OAKLAND, Calif., April 7 /PRNewswire/ -- Machaon Diagnostics, California's only independent laboratory for testing bleeding and clotting disorders has launched a clinical testing service for patients that have been prescribed warfarin. Warfarin, also known as Coumadin, Jantoven or warfarin sodium, is a potent 'blood thinner' or anticoagulant. Machaon's FDA-approved array-based technology detects genetic variations in 2 key genes involved in the metabolism of warfarin. 40% of the general...

2010-03-16 07:01:00

ATLANTA, March 16 /PRNewswire-FirstCall/ -- Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.-- in association with the Medco Research Institute(TM) -- and Mayo Clinic announced today. Results of the first nationwide prospective study examining outcomes when incorporating genetic...